Meeting to be held in Chicago on August 19 hosted by Craig-Hallum.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SCPH:
- Strong Market Presence and Strategic Advancements Drive Buy Rating for scPharmaceuticals
- Strong Financial Performance and Strategic Initiatives Justify Buy Rating for scPharmaceuticals
- scPharmaceuticals Reports Strong Q2 2025 Growth
- Promising Outlook for scPharmaceuticals: Buy Rating Supported by Strong Furoscix Demand and Strategic Growth Initiatives
- scPharmaceuticals reports Q2 EPS (34c), consensus (30c)